Amended Statement of Changes in Beneficial Ownership (4/a)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Lehr Martin A.	2. Issuer Name and Ticker or Trading Symbol Context Therapeutics Inc. [ CNTX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer
(Last) (First) (Middle) 3675 MARKET STREET, SUITE 200	3. Date of Earliest Transaction (MM/DD/YYYY) 10/22/2021
(Street) PHILADELPHIA, PA 19104 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY) 10/22/2021	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								89583	D
Common Stock	10/22/2021		O		52680	A	$7.14	0	I	Martin Lehr 2000 Trust
Common Stock	10/22/2021		C		210715	A	⁽¹⁾	210715	I	Martin Lehr 2000 Trust
Common Stock	10/22/2021		C		586475	A	⁽²⁾	797190	I	Martin Lehr 2000 Trust
Common Stock	10/22/2021		P		10000	A	$5	807190	I	Martin Lehr 2000 Trust

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrant (right to buy)	$7.14	10/22/2021		O		52680		12/20/2020	12/20/2030	Common Stock	52680.0	$0	0	I	Martin Lehr 2000 Trust
Series A Preferred Stock	⁽¹⁾	10/22/2021		C			210715	⁽³⁾	⁽¹⁾	Common Stock	210715.0	⁽¹⁾	7	I	Martin Lehr 2000 Trust
Series Seed Preferred Stock	⁽²⁾	10/22/2021		C			586475	⁽³⁾	⁽²⁾	Common Stock	586475.0	⁽²⁾	1	I	Martin Lehr 2000 Trust

Explanation of Responses:
(1)	Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
(2)	Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
(3)	Fully vested.

Remarks:
The attached amends and restates the Form 4 filed on October 25, 2021 in its entirety

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Lehr Martin A. 3675 MARKET STREET SUITE 200 PHILADELPHIA, PA 19104	X		Chief Executive Officer